Article

Global Health Epidemiology Reference Group (GHERG). Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990-2010: a systematic review and analysis

Nossal Institute for Global Health, University of Melbourne, Australia.
The Lancet (Impact Factor: 45.22). 07/2013; 381(9882). DOI: 10.1016/S0140-6736(13)60221-4

ABSTRACT

Background China is increasingly facing the challenge of control of the growing burden of non-communicable diseases. We assessed the epidemiology of Alzheimer's disease and other forms of dementia in China between 1990, and 2010, to improve estimates of the burden of disease, analyse time trends, and inform health policy decisions relevant to China's rapidly ageing population. Methods In our systematic review we searched for reports of Alzheimer's disease or dementia in China, published in Chinese and English between 1990 and 2010. We searched China National Knowledge Infrastructure, Wanfang, and PubMed databases. Two investigators independently assessed case defi nitions of Alzheimer's disease and dementia: we excluded studies that did not use internationally accepted case defi nitions. We also excluded reviews and viewpoints, studies with no numerical estimates, and studies not done in mainland China. We used Poisson regression and UN demographic data to estimate the prevalence (in nine age groups), incidence, and standardised mortality ratio of dementia and its subtypes in China in 1990, 2000, and 2010. Findings Our search returned 12 642 reports, of which 89 met the inclusion criteria (75 assessed prevalence, 13 incidence, and nine mortality). In total, the included studies had 340 247 participants, in which 6357 cases of Alzheimer's disease were recorded. 254 367 people were assessed for other forms of dementia, of whom 3543 had vascular dementia, frontotemporal dementia, or Lewy body dementia. In 1990 the prevalence of all forms of dementia was 1·8% (95% CI 0·0–44·4) at 65–69 years, and 42·1% (0·0–88·9) at age 95–99 years. In 2010 prevalence was 2·6% (0·0–28·2) at age 65–69 years and 60·5% (39·7–81·3) at age 95–99 years. The number of people with dementia in China was 3·68 million (95% CI 2·22–5·14) in 1990, 5·62 million (4·42–6·82) in 2000, and 9·19 million (5·92–12·48) in 2010. In the same period, the number of people with Alzheimer's disease was 1·93 million (1·15–2·71) in 1990, 3·71 million (2·84–4·58) people in 2000, and 5·69 million (3·85–7·53) in 2010. The incidence of dementia was 9·87 cases per 1000 person-years, that of Alzheimer's disease was 6·25 cases per 1000 person-years, that of vascular dementia was 2·42 cases per 1000 person-years, and that of other rare forms of dementia was 0·46 cases per 1000 person-years. We retrieved mortality data for 1032 people with dementia and 20 157 healthy controls, who were followed up for 3–7 years. The median standardised mortality ratio was 1·94:1 (IQR 1·74–2·45). Interpretation Our analysis suggests that previous estimates of dementia burden, based on smaller datasets, might have underestimated the burden of dementia in China. The burden of dementia seems to be increasing faster than is generally assumed by the international health community. Rapid and eff ective government responses are needed to tackle dementia in low-income and middle-income countries.

Download full-text

Full-text

Available from: Wei Wang
  • Source
    • "On the whole, this is a welcome social transformation that must be credited, at least in part, to the success of medical research. On the downside, dementias related to old age, particularly those classified as Alzheimer's disease (AD), are on an increase and this threatens to reverse the improvements in the quality of life at personal, family as well as social level, not only in the developed Western countries but also elsewhere[5,6]. It is, therefore, of paramount importance that more effort is directed towards finding causes and mechanisms of AD so that better prevention strategies and more effective management of the condition can be developed. AD is distinct from " normal " brain aging; it has a particular course and specific pathology[reviews: 7,8]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Dementias of old age, in particular Alzheimer's disease (AD), pose a growing threat to the longevity and quality of life of individuals as well as whole societies world-wide. The risk factors are both genetic and environmental (life-style) and there is an overlap with similar factors predisposing to cardiovascular diseases (CVD). Using a case–control genetic approach, we have identified a SNP (rs10507391) in ALOX5 gene, previously associated with an increased risk of stroke, as a novel genetic risk factor for AD. ALOX5 gene encodes a 5′-lipoxygenase (5′-LO) activating protein (FLAP), a crucial component of the arachidonic acid/leukotriene inflammatory cascade. A-allele of rs4769874 polymorphism increases the risk of AD 1.41-fold (p < 0.0001), while AA genotype does so 1.79-fold (p < 0.0001). In addition, GG genotype of rs4769874 polymorphism is associated with a modest increase in body mass index (BMI). We discuss potential biochemical mechanisms linking the SNP to AD and suggest possible preventive pharmacotherapies some of which are based on commonly available natural products. Finally, we set the newly identified AD risk factors into a broader context of similar CVD risk factors to generate a more comprehensive picture of interacting genetics and life-style habits potentially leading to the deteriorating mental health in the old age.
    Full-text · Article · Jan 2016
  • Source
    • "Nevertheless, our study identified that decline in cognitive function is a risk factor for institutionalization. The role of cognitive decline as a risk factor for placement in elder care homes is of particular interest because China has more than nine million people with some form of dementia and more cases of Alzheimer's disease than any other country (Chan et al., 2013), and the growing population of cognitively impaired older adults (especially those with Alzheimer's and other forms of dementia) is presenting a huge challenge to Chinese health and social care systems (Khan & Loo, 2014; Upson, 2014). Unlike most developed countries, where the predominant objective of nursing homes is to provide care for persons who are physically or cognitively impaired, most elder care institutions in China tend to preferentially accept younger, healthier, or non-disabled older adults (Balfour, 2012; Dong & Wu, 2010; Span, 2011). "
    [Show abstract] [Hide abstract]
    ABSTRACT: To examine rates of institutionalization of Chinese older adults aged 65+ and the impact of changes in health status on the likelihood of institutionalization. Using data from the 2002, 2005, 2008, and 2011 waves of the Chinese Longitudinal Healthy Longevity Survey (CLHLS), admission rates for each 3-year interval between waves were calculated. Logistic regression models were used to assess the changes of five health status variables as risk factors. Between the first (2002-2005) and third (2008-2011) intervals, the institutionalization rate increased from 0.5% to 0.8%. Risk of institutionalization increased 70% for respondents with declining ability to perform activities of daily living, 53% for those with declining cognitive function, and 44% for those with increasing number of chronic diseases. Development of policies and programs to improve older adults' health status is essential to delay institutionalization. Quality of workforce is also critical in meeting the care needs. © The Author(s) 2015.
    Full-text · Article · Apr 2015 · Journal of Aging and Health
  • Source
    • "Alzheimer's disease (AD) is rapidly becoming a major cause of morbidity and mortality as an increasing number of people live into their 70 and 80 s, the most common age of disease onset (Mayeux and Stern, 2012; Chan et al., 2013). AD is characterized by the progressive deterioration of cognitive function with an insidious impairment of short-term memory that becomes amplified to the point of inability to perform even the simplest tasks. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Humans have long pondered the nature of their mind/brain and, particularly why its capacities for reasoning, communication and abstract thought are far superior to other species, including closely related anthropoids. This article considers superior pattern processing (SPP) as the fundamental basis of most, if not all, unique features of the human brain including intelligence, language, imagination, invention, and the belief in imaginary entities such as ghosts and gods. SPP involves the electrochemical, neuronal network-based, encoding, integration, and transfer to other individuals of perceived or mentally-fabricated patterns. During human evolution, pattern processing capabilities became increasingly sophisticated as the result of expansion of the cerebral cortex, particularly the prefrontal cortex and regions involved in processing of images. Specific patterns, real or imagined, are reinforced by emotional experiences, indoctrination and even psychedelic drugs. Impaired or dysregulated SPP is fundamental to cognitive and psychiatric disorders. A broader understanding of SPP mechanisms, and their roles in normal and abnormal function of the human brain, may enable the development of interventions that reduce irrational decisions and destructive behaviors.
    Full-text · Article · Aug 2014 · Frontiers in Neuroscience
Show more